Forbes - No Silver Bullets

Plus: Celebrities donate plasma for a cure

It’s been a disappointing day for drug news. Dozens of medications are currently being tested around the world to see if they can help treat COVID-19, but so far none of them have proven helpful. Today, new research showed that HIV drug Kaletra and flu drug Arbidol have no effect on patients with the virus. A preprint of a paper was also released showing hydroxychloroquine, a potential treatment touted often by President Trump, had no benefit for coronavirus patients either (and in fact, made some of them worse). What does this mean? We can keep searching for a medication to treat coronavirus, but it is likely there won’t be a silver bullet anytime soon.

Business

Stocks plunge and oil prices continue to drop in our coronavirus economy.

Few companies are doing well right now, but Netflix continues to gain subscribers.

States are already draining their unemployment funds, meaning they might need a federal bailout in the future.

Georgia is taking aggressive steps to reopen the economy, and some businesses could be open as early as Friday.

The Rockefeller Foundation announced a new plan to increase national coronavirus testing, plus a $15 million investment.

Science & Health

A new study came out that claimed the COVID-19 death rate might be significantly lower than reported, but many experts pushed back against the methods used.

Feeling isolated? New research shows that there are ways you can still feel social even without people.

A report finds that more people are getting accidentally poisoned from household cleaning products, including disinfectants.

Tracker of the day

Startups Failure Tracker: coronavirus is slowing down venture capital, leading to more startups closing.